Abstract
Background: Olanzapine is commonly utilized in palliative care for the treatment of nausea, and a known side effect of olanzapine is increased appetite. Olanzapine is also known to cause re-emergence of eating disorders (EDs) in patients utilizing olanzapine for its antipsychotic effects. It is unclear to what extent this may also occur in patients with serious/life-limiting illness. Methods and Results: We present a case of a 70-year-old female with recurrent ovarian cancer and a history of bulimia nervosa (BN) that developed resurgence of her BN after initiation of olanzapine for cancer-associated nausea. Her BN resolved with reducing the dose of olanzapine. Conclusion: It is important to recognize that recurrence of EDs can occur when using olanzapine in the palliative care setting.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 231-233 |
| Number of pages | 3 |
| Journal | Journal of Palliative Medicine |
| Volume | 22 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 2019 |
Keywords
- feeding and eating disorders
- nausea
- palliative
ASJC Scopus subject areas
- General Nursing
- Anesthesiology and Pain Medicine
Fingerprint
Dive into the research topics of 'Resurgence of Eating Disorders with Olanzapine'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS